A Phase IV, Randomized, Controlled, Single-Blind, Multi-Center Study in Children to Evaluate the Safety, Tolerability and Immunogenicity of Two TBE Vaccines Administered According to Two Different Schedules

Trial Profile

A Phase IV, Randomized, Controlled, Single-Blind, Multi-Center Study in Children to Evaluate the Safety, Tolerability and Immunogenicity of Two TBE Vaccines Administered According to Two Different Schedules

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Feb 2015

At a glance

  • Drugs Tick-borne encephalitis vaccine (Primary)
  • Indications Encephalitis; Encephalitis virus infections
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Novartis Vaccines
  • Most Recent Events

    • 19 Jul 2011 Status of the extension trial is completed as reported by ClinicalTrials.gov (NCT01106482).
    • 19 Jul 2011 Status of the extension trial is completed as reported by ClinicalTrials.gov (NCT01106482).
    • 19 Jul 2011 Actual end date of the extension trial changed from Aug 2011 to May 2011 as reported by ClinicalTrials.gov (NCT01106482).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top